“They Call Us Cheaters”: Exploring Stigma Management Communication Strategies During GLP-1 Medication Use
As GLP-1 receptor agonist medications become more popular, conversations surrounding the medication’s use are becoming increasingly more complicated. Emerging research suggests that individuals taking these medications often feel stigmatized. However, understanding how individuals manage stigma through communication is less explored. Using stigma management communication theory, the current study seeks to better understand how individuals communicatively manage stigma surrounding GLP-1 medication use. A reflexive thematic analysis of interviews with GLP-1 users (n = 34) suggests that individuals evaluate their interpretations of both their own self-stigma and the public’s understanding of GLP-1 and engage in various different stigma management communication strategies in response. These strategies, while effective for stigma management, may inadvertently contribute to ongoing stigmatizing discourse surrounding GLP-1 use.
Authors
- Sarah F. Price (ORCID: https://orcid.org/0000-0003-0843-6688)
- Braidyn Lazenby (ORCID: https://orcid.org/0000-0002-2962-5982)
- Tursynay Alikhanova
- Md Sazzad Mahmud Shuvo
- Ashley Marie Guidry (ORCID: https://orcid.org/0009-0000-0708-6650)
- Chloe Morrison
- Nicole Davis
- Madison Lenard
Institutions
- Florida State University (US)
- New York City College of Technology (US)
- The University of Texas at Austin (US)
Publication Details
- Journal
- Health Communication
- Published
- 2026-09-18
- DOI
- https://doi.org/10.1080/10410236.2026.2734167
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00